tolvaptan has been researched along with Hypernatremia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosomi, K; Kawabata, K; Uno, T; Yokoyama, S | 1 |
| Fukuoka, H; Hoshida, S; Inoue, S; Inui, H; Minamisaka, T; Mine, K; Shinoda, Y; Tachibana, K; Ueda, K; Ueno, K | 1 |
| Imai, S; Kashiwagi, H; Miyai, T; Momo, K; Sato, Y; Sugawara, M; Takekuma, Y | 1 |
| Inomata, T; Kinugawa, K; Sato, N; Shibasaki, Y; Shimakawa, T; Yasuda, M | 1 |
| Li, GS; Li, T | 1 |
| Hatano, M; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Komuro, I; Maki, H; Minatsuki, S; Muraoka, H; Yao, A | 1 |
| Hensen, J | 1 |
| Blais, JD; Chapman, AB; Czerwiec, FS; Devuyst, O; Gansevoort, RT; Grantham, JJ; Higashihara, E; Ouyang, J; Perrone, RD; Torres, VE | 1 |
| Hirai, K; Inoue, K; Ishii, H; Itoh, K; Kadoiri, T; Moriwaki, H; Shimomura, T; Shimoshikiryo, T; Tsuji, D | 1 |
| Kettritz, R; Luft, FC | 1 |
| Tsukada, YT | 1 |
| Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M | 1 |
1 review(s) available for tolvaptan and Hypernatremia
| Article | Year |
|---|---|
[Disorders of fluid and electrolyte balance].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2011 |
1 trial(s) available for tolvaptan and Hypernatremia
| Article | Year |
|---|---|
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Topics: Adult; Albuminuria; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypernatremia; Hypertension; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Pain; Polycystic Kidney, Autosomal Dominant; Severity of Illness Index; Tolvaptan | 2016 |
10 other study(ies) available for tolvaptan and Hypernatremia
| Article | Year |
|---|---|
Trends in tolvaptan prescription and the association between hypernatremia and aging in tolvaptan-treated patients in Japan: Real-world data mining using Japanese databases.
Topics: Aged; Aging; Antidiuretic Hormone Receptor Antagonists; Data Mining; East Asian People; Heart Failure; Humans; Hypernatremia; Japan; Tolvaptan | 2023 |
Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Blood Pressure; Female; Heart Failure; Hospitalization; Humans; Hypernatremia; Male; Potassium; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tolvaptan; Treatment Outcome | 2020 |
A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database.
Topics: Antidiuretic Hormone Receptor Antagonists; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Databases, Factual; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Hypernatremia; Japan; Liver Function Tests; Male; Middle Aged; Sodium; Tolvaptan | 2021 |
Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure.
Topics: Aged; Creatinine; Female; Heart Failure; Humans; Hypernatremia; Incidence; Japan; Male; Middle Aged; Potassium; Sodium; Tolvaptan; Urea | 2018 |
Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypernatremia; Male; Sodium; Stroke Volume; Tolvaptan | 2019 |
Urine sodium excretion after tolvaptan administration is dependent upon baseline serum sodium levels: a possible explanation for the improvement of hyponatremia with scarce chance of hypernatremia by a vasopressin receptor antagonist.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hypernatremia; Hyponatremia; Male; Middle Aged; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2014 |
[Hyponatremia and tolvaptan : what is the situation 5 years after approval?].
Topics: Benzazepines; Chemical and Drug Induced Liver Injury; Diuretics; Drug Approval; Evidence-Based Medicine; Germany; Hypernatremia; Hyponatremia; Risk Assessment; Tolvaptan; Treatment Outcome | 2015 |
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypernatremia; Male; Middle Aged; Risk Factors; Tolvaptan | 2016 |
[Adverse effects of cardiovascular agents in Japan--update 2012].
Topics: Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Aspirin; Benzazepines; Cardiovascular Agents; Drug Combinations; Embolism; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Hypernatremia; Japan; Platelet Aggregation Inhibitors; Substance Withdrawal Syndrome; Tolvaptan | 2012 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypernatremia; Kidney Function Tests; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Time Factors; Tolvaptan; Urination | 2013 |